Notes
Premature mortality among males (<65) declined from 24.4% in 1984-6 to 16% in 2004-6; and among females from 14.9% to 11.1% over the same period.
Over the last 20 years the chances of a 65 year-old women reaching the age of 80 have improved from 61% to 71%. Although the odds for a 65 year old man are not so good, they are still better than evens (59%), and much better than they were 20 years ago (41%).
This is not true for all developing world. Some countries, such as the USA and Netherlands, have experienced relative stagnation in mortality improvement, especially among women (Mesle & Vallin).
In 1981, the gap in life expectancy at birth was 6 years. In 2006 it was 4.3 years, which is relatively low for a rich country at the beginning of the 21st century.
The relative gap in death rates between upper and lower socio-economic groups has grown more in northern Europe (inc. the Nordic countries) than in the south.
Although analysis of mortality by ‘underlying cause’ suggests that stroke mortality in the UK has been declining more slowly than CHD mortality in recent years—indicative perhaps of a slowdown in the well-recognised long-term secular decline in stroke mortality—Goldacre et al. (2008) have argued that a revision of these estimates may be in order (at least for the UK), since mortality based on underlying cause alone misses about one-quarter of all stroke-related deaths.
Combined life expectancy at birth would reach 100 years before the end of the century.
Though we should not underestimate the difficulties and disagreements involved in determining what the ‘present’ trajectory is.
This is not to say that the data on recent trends might not indicate that there has in fact been a compression of disability over, say, the last 20 years; and this trend may provide the basis for a ‘best-bet’ projection for the future.
When this argument was first developed, dementia was classified as a non-fatal degenerative disease. It now appears as a cause of death on death certificates. Although this change weakens the force of the distinction between fatal and non-fatal degenerative disease, the essential point remains the same.
This compares with the estimate of 6–7 years of life lost at age 40 for obese non-smokers in the Framingham cohort (Peeters et al. 2003)
Olshansky et al. (1990) estimated that the elimination of mortality from cancer would add 3.2 years to life expectancy at birth in the USA.
Though presumably it might take quite some time to have this kind of population-wide effect.
References
Barker, D. J. P. (1995). Fetal origins of coronary heart disease. BMJ, 311, 171–174.
Bunker, J. (2001). The role of medical care in contributing to health improvements within societies. International Journal of Epidemiology, 30, 1260–1263.
Carey, J. (2003). Life span: a conceptual overview. In J. Carey & S. Tuljapurkar (eds.), Life span: evolutionary, ecological and epidemiological perspectives. Supplement to vol. 29 Population and Development Review.
Carnes, B. A., & Olshansky, S. J. (2007). A realist view of aging, mortality, and future longevity. Population and Development Review, 33(2), 367–381.
Cutler, D. (2004). Your money or your life. Oxford University Press. See technical appendix at http://post.economics.harvard.edu/faculty/dcutler/book/technical_appendix.pdf.
Cutler, D., et al. (2006). The determinants of mortality. NBER working paper 11963. National Bureau of Economic Research.
Davies, A. R., et al. (2007). Contributions of changing incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996–2005. European Heart Journal, 28, 2142–2147.
DHHS. (2006). Regenerative medicine. Washington DC: Department of Health and Human Sciences.
Doll, R., et al. (2004). Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ, 328, 1519. Epub 2004 June 22.
Fogel, R. W. (2003). Secular trends in physiological capital: implications for equity in health care. Perspectives in Biology and Medicine, 46(3), S24–S38.
Fogel, R. W., & Costa, D. L. (1997). A theory of technophysio evolution, with some implications for forecasting population health care costs, and pension costs. Demography, 34, 49–66.
Fries, J. (1980). Aging, natural death and the compression of morbidity. New England Journal of Medicine, 303, 130–135.
Edwards, R. D., & Tuljapurkar, S. (2005). Inequality in life spans and a new perspective on mortality convergence across industrialized countries. Population and Development Review, 31, 645–674.
Gjonca, A., et al. (2005). Sex differences in mortality, a comparison of the United Kingdom and other developed countries. Health Statistics Quarterly, 26, 6–16.
Goldacre, M., et al. (2008). Mortality rates for stroke in England form 1979 to 2004. Trends, diagnostic precision and artifacts. Stroke, published online June 2008.
Gruenberg, E. M. (1977). The failure of success. Milbank Memorial Fund Quarterly, 55, 3–24.
Health Development Agency. (2004). The smoking epidemic in England. London: HDA.
Jagger, C., et al. (2007). Cohort differences in disease and disability in the young-old: findings from the MRC cognitive function and ageing study. BMC Public Health, 7, 156.
Janssen, F., Kunst, A., & Mackenbach, J. (2007). Variations in the pace of old-age mortality decline in seven European countries, 1950–1999: the role of smoking and the factors earlier in life. European Journal of Population, 23(2), 171–188.
Jeune, B. (2007). Explanation of the decline in mortality in the oldest-old: the impact of circulatory diseases. In J.-M. Robine, et al. (Eds.), Human longevity, individual life duration, and the growth of the oldest-old population. Dordrecht: Springer.
Kelly, M., & Capewell, S. (2004). Relative contributions of changes in risk factors and treatment to the reduction in coronary heart disease mortality. NHS Health Development Agency Briefing Paper. HDA: London.
Lafortune, G., et al. (2007). Trends in severe disability among elderly people: assessing the evidence in 12 OECD countries and the future implications. OECD Health Working Papers no. 26. Paris: Organisation for Economic Cooperation and Develop.
Langenberg, C., et al. (2005). Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. American J Public Health, 94(6), n28–n632.
Law, M. R., & Morris, J. K. (1998). Why is mortality higher in poorer areas and in more northern areas of England and Wales? Journal of Epidemiology and Community Health, 52(6), 344–352.
Leyland, A. H., et al. (2004). Increasing inequalities in premature mortality in Great Britain. Journal of Epidemiology and Community Health, 58(4), 296–302.
Lichtenberg, F. R. (2007). The impact of new drugs on US longevity and medical expenditure, 1990–2003: evidence from longitudinal, disease-level data. American Economic Review, 97(2), 438–443.
Mackenbach, J. P., et al. (2003). Widening social inequalities in mortality in six western European countries. International Journal of Epidemiology, 32, 830–837.
Mackenbach, J. P., European Union Working Group on Socioeconomic Inequalities in Health, et al. (2008). Socioeconomic inequalities in health in 22 European countries. The New England journal of medicine, 358(23), 2481.
Manton, K. G., et al. (1991). Limits to human life expectancy: evidence, prospects, and implications. Population and Development Review;, 17, 603–637.
Meara, E. R., Richards, S., & Cutler, D. M. (2008). The gap gets bigger: changes in mortality and life expectancy, by education, 1981–2000. Health Affairs, 27(2), 350–360.
Oeppen, J., & Vaupel, J. (2002). Broken limits to life expectancy. Science, 296, 1029–1030.
O’Flaherty, M., et al. (2008). Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart, 94, 178–181.
Olshansky, S. J., et al. (1990). In search of Methuselah: Estimating the upper limits to human longevity. Science, 250, 634–640.
Olshansky, J., et al. (2005). A potential decline in life expectancy in the United States in the 21st century. New England Journal of Medicine, 352, 1138–1145.
ONS. (2006). Trends in life expectancy by social class. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=8460. Accessed July 2008.
Pampel, F. (2003). Declining sex differences in mortality from lung cancer in high-income nations. Demography, 40(1), 45–65.
Peeters, A., The Netherlands Epidemiology and Demography Compression of Morbidity Research Group, et al. (2003). Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Annals of Internal Medicine, 138(1), 24–32.
PENSIONS COMMISSION,(2005). A new pension settlement for the 21st century. The second report of the pensions commission. Appendices. London: TSO.
President’s Commission on Bioethics. (2003). Beyond therapy. Washington DC. www.bioethics.gov.
Quinn, M., et al. (2001). Cancer trends in England and Wales 1950 to 1999. London: Office for National Statistics.
Ramsay, S. E., et al. (2008). Are social inequalities in mortality in Britain narrowing? Time trends from 1978 to 2005 in a population-based study of older men. Journal of Epidemiology and Community Health, 62, 75–80.
Rothwell, P. M., et al. (2004). Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet, 363, 925–933.
Unal, B., et al. (2004). Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation, 109(9), 1101–1107.
Wells, C., & Gordon, E. (2008). Geographical variations in premature mortality in England and Wales, 1981–2006. Health Statistics Quarterly, 38, 6–18.
Westlake, S., & Cooper, N. (2008). Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993 to 2004. Health Statistics Quarterly, 38, 33–46.
Wilmoth, J. (2000). Demography of longevity: past, present and future trends. Experimental Gerontology, 35, 1111–1119.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Howse, K., Harper, S. Review of Longevity Trends in the United Kingdom to 2025 and Beyond. Population Ageing 1, 225–240 (2008). https://doi.org/10.1007/s12062-009-9014-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12062-009-9014-4